Remote glucose check
This article was originally published in The Gray Sheet
Scottsdale, Ariz., health technology firm MedApps gains 510(k) clearance for its d-PAL remote monitoring system for diabetics July 3. The system connects to Johnson & Johnson/LifeScan's One Touch Ultra glucose monitor to allow wireless transfer of daily glucose readings to a central server. Patients can interact with the system via cell phone and remotely answer additional questions to give their doctors other pertinent information. MedApps, founded in July 2006, is developing similar products to monitor blood pressure in congestive heart failure patients, breathing efficiency for respiratory diseases, tremors in Parkinson's disease, and for use with implantable defibrillators and pacemakers...
You may also be interested in...
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.
The two companies announced more details about their COVID-19 vaccine development plan, including a $185m upfront payment and $113m equity investment from Pfizer.